Golub Capital announced that as Sole Bookrunner and Administrative Agent it provided $85.5MM in GOLD financing and co-investment equity to support the acquisition of Certara by Arsenal Capital Partners. GOLD financings are Golub Capital's One-Loan Debt facilities.

Certara is dedicated to improving human health by delivering a broad spectrum of software products and consulting services, spanning molecular discovery to clinical development, with special focus on supporting translational approaches to drug development.   

A leading provider of model-based drug development tools, Certara was formed by the acquisition and integration of industry leaders Tripos, Simcyp, and Pharsight Corporation.

"We are excited to support Arsenal Capital Partners and the management team at Certara," said Michael Mastropaolo, Vice President at Golub Capital.  "This investment represents an attractive opportunity in the healthcare technology and services space, which is a target segment for both our Software, Digital and Technology vertical and our Healthcare vertical.  We value Arsenal's disciplined investing approach in this sector, as well as their deep industry expertise."

"Golub Capital has proven to be a valuable partner in this transaction," said Gene Gorbach, Principal at Arsenal Capital Partners.  "They provided a streamlined financing solution to support the acquisition of Certara, and lived up to the high standard of execution they have established for themselves in the market."

With over $8 billion of capital under management, Golub Capital is a leading provider of financing solutions for the middle market, including one-loan financings (through the firm's proprietary MiniGOLD, GOLD, and MegaGOLD facilities), senior, second lien, and subordinated debt, preferred stock and co-investment equity. The firm underwrites and syndicates senior credit facilities up to $300 million. Golub Capital's hold sizes range up to $250 million per transaction.